Table 6.
Variable | AMR+ DSA+ (N=4) | AMR+ DSA- (N=2) | AMR- DSA- (N=4) |
---|---|---|---|
Endomyocardial biopsy | |||
C4d stain positive | 4 (100%) | 2 (100%) | 0 |
CD68 stain positive | 2 (50%) | 0 | 0 |
Macrophage infiltration | 2 (50%) | 1 (50%) | 0 |
Endothelial swelling | 1 (25%) | 1 (50%) | 0 |
AMR grade* | |||
0 | 0 | 0 | 4 (100%) |
1 | 4 (100%) | 2 (100%) | 0 |
ACR grade* | |||
0R | 2 (50%) | 1 (50%) | 4 (100%) |
1R | 2 (50%) | 1 (50%) | 0 |
2R | 0 | 0 | 0 |
3R | 0 | 0 | 0 |
Transplant rejection score | 0.4 ± 0.2 | 0.4 ± 0.2 | 0.3 ± 0.2 |
Coronary angiography | |||
Normal coronary arteries | 2 (50%) | 1 (50%) | 1 (25%) |
Coronary atherosclerosis* | |||
Mild | 2 (50%) | 1 (50%) | 3 (75%) |
Moderate | 0 | 0 | 0 |
Severe | 0 | 0 | 0 |
Intravascular ultrasound performed | 1 (25%) | 0 | 1 (25%) |
†Significant CAV | 0 | 0 | 0 |
According to International Society for Heart and Lung Transplantation criteria.
Coronary stenosis of ≥70% and/or distal pruning of secondary side branches. Data are presented as mean ±standard deviation for continuous data or as frequency (percentage) for categorical data. AAD-acute allograft dysfunction, ACR-acute cellular rejection, AMR-antibody mediated rejection, CAV-coronary allograft vasculopathy, DSA-donor specific antibody.